Skip to content

AnaptysBio, Inc. ANAB Interest Paid

Interest Paid at other companies

Pfizer logo
PfizerPFE
$293M-17.0%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$10.4M-20.9%
AbbVie logo
AbbVieABBV
$750.5M+6.8%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$20.32M-12.7%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$7.82M-12.0%
Precigen logo
PrecigenPGEN
$2.56M

Other financials

Income statement

See full
Revenue$25.6M-8.0%
Operating income-$34.6M-25.8%
Net income-$52.9M-34.5%
EPS (diluted)-$1.84-43.8%

Balance sheet

See full
Cash & equivalents$248.5M+152%
Total debt$13.6K-99.9%
Total equity$12.7M-62.5%
Total assets$329.7M-21.9%

Cash flow

See full
Operating cash flow-$25.9M-142%
CapEx$17.0K-51.4%
Free cash flow-$25.9M-142%

Valuation

See full
Market cap$1.73B+180%
Enterprise value$1.48B+176%
P/S7.4×+1.9×

Profitability

See full
Operating margin17.6%+9.6pp
Net margin-49.9%-22.6pp
FCF margin1.9%+1.0pp

Returns & leverage

See full
Return on equity-343.8%-1,012pp
Debt / equity-0.5×
Current ratio7.6×-0.7×

Where this comes from

Reported directly by AnaptysBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about AnaptysBio, Inc.'s interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AnaptysBio, Inc.'s interest paid?
AnaptysBio, Inc. (ANAB) reported interest paid of $20.83M in Q1 2026.
How has AnaptysBio, Inc.'s interest paid changed year-over-year?
AnaptysBio, Inc.'s interest paid increased by 15.1% year-over-year, from $18.1M to $20.83M.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.